Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin L Chen

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2014
Development of novel activin-targeted therapeuticsJustin L Chen, Kelly L Walton, Sara L Al-Musawi, et al.
The Journal of Cell Biology|October 23, 2013
The bone morphogenetic protein axis is a positive regulator of skeletal muscle massCatherine E Winbanks, Justin L Chen, Hongwei Qian, et al.
The Journal of Cell Biology|June 20, 2012
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatinCatherine E Winbanks, Kate L Weeks, Rachel E Thomson, et al.
Science Translational Medicine|July 22, 2016
Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in miceCatherine E Winbanks, Kate T Murphy, Bianca C Bernardo, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2014
Development of novel activin-targeted therapeuticsJustin L Chen, Kelly L Walton, Sara L Al-Musawi, et al.
The Journal of Cell Biology|October 23, 2013
The bone morphogenetic protein axis is a positive regulator of skeletal muscle massCatherine E Winbanks, Justin L Chen, Hongwei Qian, et al.
The Journal of Cell Biology|June 20, 2012
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatinCatherine E Winbanks, Kate L Weeks, Rachel E Thomson, et al.
Science Translational Medicine|July 22, 2016
Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in miceCatherine E Winbanks, Kate T Murphy, Bianca C Bernardo, et al.
Pageof 2